ARTICLE | Clinical News
XaraColl regulatory update
November 22, 2016 12:40 AM UTC
Innocoll submitted an NDA to FDA for XaraColl bupivacaine collagen-matrix implants to treat post-surgical pain. The company hopes to launch the biodegradable and bioresorbable collagen/bupivacaine mat...
BCIQ Company Profiles